197 related articles for article (PubMed ID: 22405130)
21. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
[TBL] [Abstract][Full Text] [Related]
22. Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry.
Shimojima M; Ströher U; Ebihara H; Feldmann H; Kawaoka Y
J Virol; 2012 Feb; 86(4):2067-78. PubMed ID: 22156524
[TBL] [Abstract][Full Text] [Related]
23. Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.
Kunz S; Sevilla N; McGavern DB; Campbell KP; Oldstone MB
J Cell Biol; 2001 Oct; 155(2):301-10. PubMed ID: 11604425
[TBL] [Abstract][Full Text] [Related]
24. Autophagy Promotes Infectious Particle Production of Mopeia and Lassa Viruses.
Baillet N; Krieger S; Journeaux A; Caro V; Tangy F; Vidalain PO; Baize S
Viruses; 2019 Mar; 11(3):. PubMed ID: 30909570
[TBL] [Abstract][Full Text] [Related]
25. Human LAMP1 accelerates Lassa virus fusion and potently promotes fusion pore dilation upon forcing viral fusion with non-endosomal membrane.
Zhang Y; Carlos de la Torre J; Melikyan GB
PLoS Pathog; 2022 Aug; 18(8):e1010625. PubMed ID: 35969633
[TBL] [Abstract][Full Text] [Related]
26. Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1.
Wang MK; Ren T; Liu H; Lim SY; Lee K; Honko A; Zhou H; Dyall J; Hensley L; Gartin AK; Cunningham JM
PLoS Pathog; 2018 Sep; 14(9):e1007322. PubMed ID: 30265711
[TBL] [Abstract][Full Text] [Related]
27. Dystroglycan is involved in skin morphogenesis downstream of the Notch signaling pathway.
Sirour C; Hidalgo M; Bello V; Buisson N; Darribère T; Moreau N
Mol Biol Cell; 2011 Aug; 22(16):2957-69. PubMed ID: 21680717
[TBL] [Abstract][Full Text] [Related]
28. Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding.
Kunz S; Rojek JM; Kanagawa M; Spiropoulou CF; Barresi R; Campbell KP; Oldstone MB
J Virol; 2005 Nov; 79(22):14282-96. PubMed ID: 16254363
[TBL] [Abstract][Full Text] [Related]
29. Receptor use by pathogenic arenaviruses.
Reignier T; Oldenburg J; Noble B; Lamb E; Romanowski V; Buchmeier MJ; Cannon PM
Virology; 2006 Sep; 353(1):111-20. PubMed ID: 16797051
[TBL] [Abstract][Full Text] [Related]
30. Integrins and dystroglycan regulate astrocyte wound healing: the integrin beta1 subunit is necessary for process extension and orienting the microtubular network.
Peng H; Shah W; Holland P; Carbonetto S
Dev Neurobiol; 2008 Apr; 68(5):559-74. PubMed ID: 18188865
[TBL] [Abstract][Full Text] [Related]
31. Inoculation route-dependent Lassa virus dissemination and shedding dynamics in the natural reservoir -
Wozniak DM; Riesle-Sbarbaro SA; Kirchoff N; Hansen-Kant K; Wahlbrink A; Stern A; Lander A; Hartmann K; Krasemann S; Kurth A; Prescott J
Emerg Microbes Infect; 2021 Dec; 10(1):2313-2325. PubMed ID: 34792436
[TBL] [Abstract][Full Text] [Related]
32. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.
Wang P; Liu Y; Zhang G; Wang S; Guo J; Cao J; Jia X; Zhang L; Xiao G; Wang W
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899092
[No Abstract] [Full Text] [Related]
33. Current research for a vaccine against Lassa hemorrhagic fever virus.
Warner BM; Safronetz D; Stein DR
Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
[TBL] [Abstract][Full Text] [Related]
34. Virus entry. Lassa virus entry requires a trigger-induced receptor switch.
Jae LT; Raaben M; Herbert AS; Kuehne AI; Wirchnianski AS; Soh TK; Stubbs SH; Janssen H; Damme M; Saftig P; Whelan SP; Dye JM; Brummelkamp TR
Science; 2014 Jun; 344(6191):1506-10. PubMed ID: 24970085
[TBL] [Abstract][Full Text] [Related]
35. Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry.
Jae LT; Raaben M; Riemersma M; van Beusekom E; Blomen VA; Velds A; Kerkhoven RM; Carette JE; Topaloglu H; Meinecke P; Wessels MW; Lefeber DJ; Whelan SP; van Bokhoven H; Brummelkamp TR
Science; 2013 Apr; 340(6131):479-83. PubMed ID: 23519211
[TBL] [Abstract][Full Text] [Related]
36. Lassa Virus Cell Entry Reveals New Aspects of Virus-Host Cell Interaction.
Torriani G; Galan-Navarro C; Kunz S
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928003
[TBL] [Abstract][Full Text] [Related]
37. E3 Ligase ITCH Interacts with the Z Matrix Protein of Lassa and Mopeia Viruses and Is Required for the Release of Infectious Particles.
Baillet N; Krieger S; Carnec X; Mateo M; Journeaux A; Merabet O; Caro V; Tangy F; Vidalain PO; Baize S
Viruses; 2019 Dec; 12(1):. PubMed ID: 31906112
[TBL] [Abstract][Full Text] [Related]
38. Opposing roles of integrin alpha6Abeta1 and dystroglycan in laminin-mediated extracellular signal-regulated kinase activation.
Ferletta M; Kikkawa Y; Yu H; Talts JF; Durbeej M; Sonnenberg A; Timpl R; Campbell KP; Ekblom P; Genersch E
Mol Biol Cell; 2003 May; 14(5):2088-103. PubMed ID: 12802077
[TBL] [Abstract][Full Text] [Related]
39. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.
Bao X; Kobayashi M; Hatakeyama S; Angata K; Gullberg D; Nakayama J; Fukuda MN; Fukuda M
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12109-14. PubMed ID: 19587235
[TBL] [Abstract][Full Text] [Related]
40. Cell surface glycan engineering reveals that matriglycan alone can recapitulate dystroglycan binding and function.
Sheikh MO; Capicciotti CJ; Liu L; Praissman J; Ding D; Mead DG; Brindley MA; Willer T; Campbell KP; Moremen KW; Wells L; Boons GJ
Nat Commun; 2022 Jun; 13(1):3617. PubMed ID: 35750689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
